AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
15.66
-0.34 (-2.12%)
Feb 12, 2026, 4:00 PM EST - Market closed
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $763.22 million as of February 13, 2026.
Market Cap
763.22M
Enterprise Value
612.73M
1-Year Change
n/a
Ranking
Category
Stock Price
15.66
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $763.22M, a decrease of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 763.22M | -2.13% |
| Feb 11, 2026 | 779.79M | 2.89% |
| Feb 10, 2026 | 757.86M | -0.38% |
| Feb 9, 2026 | 760.78M | -2.44% |
| Feb 6, 2026 | 779.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 785.57M |
| Annexon | 778.07M |
| Maravai LifeSciences Holdings | 765.84M |
| KalVista Pharmaceuticals | 764.26M |
| Arbutus Biopharma | 757.76M |
| Bright Minds Biosciences | 755.25M |
| MapLight Therapeutics | 755.21M |
| MiMedx Group | 750.88M |